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Abstract 
Background and Purpose: In vivo identification of white matter lesions plays a key-role in 
evaluation of patients with multiple sclerosis (MS). Automated lesion segmentation methods have 
been developed to substitute manual outlining, but evidence of their performance in multi-center 
investigations is lacking. In this work, five research-domain automated segmentation methods were 
evaluated using a multi-center MS dataset. 
Methods: 70 MS patients (median EDSS of 2.0 [range 0.0-6.5] ) were included from a six-center 
dataset of the MAGNIMS Study Group (www.magnims.eu) which included 2D FLAIR and 3D T1 
images with manual lesion segmentation as a reference. Automated lesion segmentations were 
produced using five algorithms: Cascade; Lesion Segmentation Toolbox (LST) with both the Lesion 
growth algorithm (LGA) and the Lesion prediction algorithm (LPA); Lesion-Topology preserving 
Anatomical Segmentation (Lesion-TOADS); and k-Nearest Neighbor with Tissue Type Priors (kNN-
TTP). Main software parameters were optimized using a training set (N=18), and formal testing was 
performed on the remaining patients (N=52). To evaluate volumetric agreement with the reference 
segmentations, intraclass correlation coefficient (ICC) as well as mean difference in lesion volumes 
between the automated and reference segmentations were calculated. The Similarity Index (SI), False 
Positive (FP) volumes and False Negative (FN) volumes were used to examine spatial agreement. All 
analyses were repeated using a leave-one-center-out design to exclude the center of interest from the 
training phase to evaluate the performance of the method on ‘unseen’ center. 
Results: Compared to the reference mean lesion volume (4.85±7.29 mL), the methods displayed a 
mean difference of 1.60±4.83 (Cascade), 2.31±7.66 (LGA), 0.44±4.68 (LPA), 1.76±4.17 (Lesion-
TOADS) and -1.39±4.10 mL (kNN-TTP). The ICCs were 0.755, 0.713, 0.851, 0.806 and 0.723, 
respectively. Spatial agreement with reference segmentations was higher for LPA (SI=0.37±0.23), 
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Lesion-TOADS (SI=0.35±0.18) and kNN-TTP (SI=0.44±0.14) than for Cascade (SI=0.26±0.17) or 
LGA (SI=0.31±0.23). All methods showed highly similar results when used on data from a center not 
used in software parameter optimization.  
Conclusion: The performance of the methods in this multi-center MS dataset was moderate, but 
appeared to be robust even with new datasets from centers not included in training the automated 
methods. 
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1. Introduction 
Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease of the central nervous 
system, with inflammatory white matter (WM) lesions as prominent pathological hallmark.1,2 In vivo 
visualization of lesions by means of MRI plays a crucial role in the diagnosis and study of MS. 
Moreover, several clinical trials have used WM lesion volume as a (secondary) study outcome.3-6 
For clinical and research purposes, delineation of WM lesions in MS is either performed 
manually or with a semiautomatic tool. These approaches, however, are labor-intensive and suffer 
from considerable inter- and intra-rater variability.7,8 To overcome these problems, automated WM 
lesion segmentation methods have been developed in the last decade.9 However, these methods are 
not routinely applied in research, clinical trials or individual patient care. One important hurdle is the 
lack of comparative data reporting the accuracy and robustness of these methods when using data 
obtained from different centers.  Evidence of their performance in multi-center investigations is 
lacking. 
The aim of this study was, firstly, to evaluate the performance of research-domain automated 
WM lesion segmentation methods in a multi-center MS dataset with diverging scanners and 
protocols. And secondly, to investigate how these methods perform on data from a new center (using 
other centers for training). We selected five algorithms for automated segmentation: Cascade10,11; 
Lesion growth algorithm (LGA)12 and Lesion prediction algorithm (LPA)13 both from the Lesion 
Segmentation Toolbox (LST)12; Lesion-Topology-preserving Anatomical Segmentation (Lesion-
TOADS)14; and k-Nearest Neighbor with Tissue Type Priors (kNN-TTP)15.  
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2. Methods and materials  
2.1. Subjects 
The data for this study were drawn from a multi-center MS dataset that was collected by the 
MAGNIMS Study Group (www.magnims.eu) as described previously.16 For the analyses described 
in the current paper, we selected the patients with a 2D FLAIR acquisition, and we excluded three 
patients with co-morbidity (vascular disease, glioblastoma, surgical removal of part of the brain) that 
could interfere with the automated lesion segmentation and one patients whose data were acquired 
after contrast agent administration. 
This resulted in a dataset of 70 patients (67% female) that were scanned in six different 
MAGNIMS centers. Of the 70 patients, 1 was diagnosed with clinically isolated syndrome, 65 had 
relapsing-remitting MS, and 4 had secondary-progressive MS. The average age was 34.9±8.5 years 
and mean disease duration was 7.6±6.0 years from onset. The disease severity was measured using 
the Expanded Disability Status Scale (EDSS)17 on the day of scanning and scores a median of 2 
(range 0.0-6.5), see Table 1. We additionally collected data of 12 healthy controls (2 per center) from 
the larger sample (58% females; age: 31.2±7.2 years) for kNN-TTP training (see 2.4.4). Written 
informed consent had been obtained from all subjects and the institutional review boards of each 
participating center approved the study. 
 
2.2. MR imaging 
MR imaging was performed on 3.0 Tesla whole-body MR systems. Each protocol contained a 3D 
T1-weighted sequence with a (near) isotropic voxel size of approximately 1mm3 and a 2D FLAIR 
sequence with a 3.0-mm slice thickness and an in plane resolution of 0.75-1.0 mm. More details are 
listed in Table 2. 
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2.3. Manual segmentations 
The manual reference segmentations were constructed as follows: an experienced neuro-radiologist 
(YL) manually marked the lesions, after which a trained rater outlined the lesions. To assess intra-
observer variability, the rater constructed a second set of segmentations for five subjects based on the 
same markings. Furthermore, for these same five patients, the neuro-radiologist marked the lesions a 
second time after which the rater created segmentations based on these new markings, resulting in a 
third set of segmentations used for quantification of inter-rater variability.  
 
2.4. Automated WM lesion segmentation methods 
Methods were included if: the method 1) is able to segment WM lesions in a fully automated manner 
from FLAIR (and T1-weighted) images; 2) is freely available for academic research work; and 3) can 
be installed on the NCA grid cluster (www.amsterdamresearch.org/web/neuroscience). Based on 
these criteria, we selected Cascade; LGA and LPA, both from the LST; Lesion-TOADS; and kNN-
TTP. More information on the inclusion is listed in Table 9 of supplementary data. The post-
processing used is listed in Table 3 and a short description of each method is listed below. A short 
introduction on each of the methods is provided below. 
 
2.4.1. Cascade 
Cascade10,11 is an unsupervised method based on a proposed statistical definition of WML which was 
not specifically developed for MS WM lesions. The method applies a single node support vector 
machine (SVM) to preselect tissues that shows WM changes (areas with low and high intensities on 
respectively, T1 and T2 weighted images) compared to normal grey matter (GM) and WM. The WM 
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changes are tested against a statistical definition of WM lesions, and by applying a threshold (α), a 
selection of lesions is made. From this selection, a WM lesion p-value (LPV) map is created by 
applying a morphological filter and removing small lesions (lesion size < 27 mm3). Then the LPV 
map is converted to a binary mask by applying a threshold (LPV threshold). 
 
2.4.2. LGA 
LGA12, implemented in the LST, is based on a lesion growth algorithm. For pre-processing, FLAIR 
images are linearly registered to T1-weighted images, as well as the generated partial volume 
estimated (PVE) label and inverse warping of the WM tissue probability map (TPMWM). Next, WM, 
GM and cerebrospinal fluid (CSF) lesion belief maps (BWM, BGM, BCSF) are calculated and a liberal 
lesion map is created as the sum of the belief maps. By binarizing BGM with a threshold (κ) the initial 
lesion map is constructed. Lesion growing is then performed on the initial lesion map toward the 
liberal lesion map, and stopped when no more voxels are added to the lesions. Finally, the lesion-
probability (LP) map is converted to a binary lesion mask by applying an user specified lesion 
probability threshold (LPT). 
 
2.4.3. LPA 
LPA13, implemented in the Lesion Segmentation Toolbox (LST), is based on a lesion prediction 
algorithm. For pre-processing, FLAIR images are linearly registered to T1-weighted images and are 
normalized to MNI space. WM, GM and CSF are segmented and the FLAIR intensities are 
standardized by dividing each voxel by the mean of the GM segmentation followed with a 
subtraction on each voxel with the mean of the standardized GM intensities. The remaining positive 
voxels on the FLAIR images are multiplied with a WM tissue probability map and negative voxels 
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set to zero to create the LP map. Lastly, the LP map is converted to a binary lesion mask by applying 
a LPT. 
 
2.4.4. Lesion-TOADS 
Lesion-TOADS14 is a topology preserving atlas-based segmentation method. In short, Lesion-
TOADS performs fuzzy segmentation and defines topologically consistent regions with an additional 
lesion class. A relationship function is used for reducing the false positive (FP) lesions in areas where 
they commonly occur, and an intensity-weighting scheme is incorporated for optimizing the effect of 
each channel of the multichannel inputs.  
 
2.4.5. kNN-TTP 
kNN-TTP15 segments WM lesions using kNN classification extended with anatomical TTP derived 
from healthy controls. The segmentation is done by comparing the voxels of new data with a training 
set of labelled examples, which means that, in contrast to the three other methods, kNN-TTP needs a 
labelled reference data set. A leave-one-out procedure was used to correct for the use of labelled 
examples to make the method not biased. Finally, the LP map is converted to a binary lesion mask by 
applying a LPT. 
 
2.5. Training 
The patients were divided into a separate training and test set. For each center, patients were ranked 
according to reference lesion volume and three patients were then selected for the training set: the 
patient with the median lesion volume, the patient with the second lowest volume and the patient 
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with the second highest lesion volume. This resulted in a training set of 18 patients, while the 
remaining 52 patients formed the test set.  
 
2.6. Pre- and post-processing 
For LGA, LPA and kNN-TTP the data was pre-processed as based on the reports in the 
literature12,13,15 The publications on Cascade and Lesion-TOADS do not prescribe specific pre-
processing steps; therefore, the same pre-processing steps as in kNN-TTP were applied.  
Because LGA and LPA  produced the LP-maps in T1-space, the LP maps found by LGA and 
LPA were first co-registered to FLAIR space before thresholding was applied (FSL-FLIRT, 6 DOF 
and trilinear interpolation) to create the binary lesions maps. Cascade and kNN-TTP needed post-
processing to construct binary lesion maps by applying a threshold, which was optimized during the 
training phase. See Table 3 for an overview. 
 
2.7. Parameter tuning 
The performance of Cascade, LGA, LPA and kNN-TTP can be improved by optimizing method-
specific configuration parameters. For Cascade, optimal performance was assured by running the 
segmentation algorithm on the training data while sweeping the two main parameters (α={0.05, 0.10, 
…, 1.00} and LPV threshold={α, α-0.05, …, 0}).10,11 The parameter combination that provided the 
group-wise highest average spatial overlap was considered as the optimal configuration. A similar 
approach was used to derive the optimal configuration for LPA, sweeping κ={0.05, 0.10, …, 1.00} 
and LPT={0, 0.05, …, 1.00}.12 LGA and kNN-TTP were optimized by sweeping LPT={0, 0.05, …, 
1.00}. Because in kNN-TTP, the reference data are actively used in every run of the algorithm, a 
leave-one-out cross-validation was used to optimize kNN-TTP parameters to ensure independence of 
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the evaluation.15 The optimal parameter settings were selected on the highest mean spatial overlap 
(similarity coefficient (SI), see section Evaluation) compared with the manual references. 
 
2.8. Experiments 
The parameter tuning was performed several times in the following experiments, see Figure 1. 
Experiment 1) To evaluate the performance of the automated methods while tuning the 
parameters on the data of all centers. In this experiment, all parameter tuning was done using 
the full training set and subsequently tested using the full test set.  
Experiment 2) To evaluate the performance of the automated methods on new (unseen) data, 
six partial experiments were performed, treating each of the six centers in turn as the (unseen) 
center-of-interest. Each time, the data from the center-of-interest was excluded during the 
parameter tuning, and the optimized methods were then tested on the center-of-interest data.  
 
Three additional analyses were performed with the data of Experiment 1.  
1) Impact of lesion volume:  
the data was re-analyzed for subject groups with low (<5 mL), intermediate (5-15 mL) and high 
(>15 mL) lesion volume.  
2) Impact of the training set selection: 
the data was re-analyzed with use of two different training sets, selecting for training from each 
center first the three patients with lowest lesion volumes, and second the three patients with the 
highest lesion volumes. The impact of the training set composition was subsequently evaluated 
by comparing the subset of patients that were not part of any of the three training sets (N = 28). 
The agreement of the segmentations with the manual references was evaluated using SI.  
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3) Comparison of automated methods against data-driven reference: 
we assessed the performance of the algorithm against a data driven reference using the STAPLE 
algorithm.19 The STAPLE algorithm estimates the sensitivity and specificity for each automated 
segmentation compared to an estimated true segmentation derived by STAPLE. 
 
2.9. Evaluation 
The method-wise performance was evaluated by examining volumetric and spatial agreement of the 
automated methods with the manual reference segmentation. The segmentations of Experiment 2 
were evaluated as one group, despite differences in optimized parameters depending on the centers 
included in the parameter tuning in order to provide a complete assessment of the performance on 
unseen data that can be directly compared with the results of Experiment 1.  
 For volumetric agreement, the mean difference in lesion volume between the automated 
segmentation and the manual reference segmentation was evaluated. Furthermore, the intra-class 
correlation coefficient (ICC, two-way mixed model with absolute agreement)20 was calculated. 
Spatial agreement between the methods and the manual reference was evaluated using the Dice 
similarity index21: 
𝑆𝐼 = (2 × 𝑇𝑃) (2 × 𝑇𝑃 + 𝐹𝑃 + 𝐹𝑁⁄ ), 
where TP, FP and FN are, respectively, true positive, false positive and false negative volume. To 
determine the origin of  spatial disagreement, we also computed the detection error rate (DER; the 
detection error volume divided by mean total volume) to quantify the effect of missed and false 
positive lesions on spatial disagreement, and the outline error rate (OER; the outline error volume 
divided by mean total volume) to quantify the effect of altered boundaries of correctly detected 
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lesions (see supplementary data for equations of DER and OER).15,22 Finally, FP and FN volumes 
were determined for the results of Experiment 1.  
 
3. Results 
An overview of the optimal configurations derived in the training phase of both experiments is 
provided in Table 4. Figure 2 displays a typical example of FLAIR image, the corresponding manual 
reference segmentation and the corresponding automated segmentation results.  
The voxelwise intra-rater variability was SI=0.73±0.11 (mean±SD) when comparing the first and 
second segmentations and 0.75±0.11 when comparing the segmentations on the first and second 
marking of the lesions.  
 
3.1. Volumetric agreement  
The average lesion volume measured by the manual rater was 4.85±7.29 mL, which is in the 
expected range for an MS cohort with the given demographic and clinical features (see also Table 1). 
Scatterplots of the lesion volumes with correlation coefficients found by the automated methods 
versus the volumes of the manual outlined lesions are shown in Figure 3. The mean volumetric 
difference and ICC between the automated segmentation results and the manual reference 
segmentations are presented in Table 5.  
In Experiment 1, Cascade, LPA and kNN-TTP showed the smallest deviation from the 
manual reference in terms of lesion volume (mean difference: 0.60±4.83, 0.44±4.68 and-1.39±4.10 
mL, respectively), compared to LGA and Lesion-TOADS (mean difference: 2.31±7.66 mL and 
1.76±4.17, respectively). Figure 4 shows boxplots of this volume differences for both experiments 
and each center.  
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In Experiment 2, with testing on new centers, LPA showed on average the largest differences: 
larger deviations and lower ICC were observed (see Table 5) compared to Experiment 1. The 
volumetric performance of Cascade, LGA and kNN-TTP was less affected by the different training. 
Because Lesion-TOADS does not use training or optimization, results for Experiment 2 were 
identical to those for Experiment 1. 
 
3.2. Spatial agreement   
The average SI, DER, OER and FN and FP volumes of the automated segmentation methods 
compared to the manual reference are presented in Table 5. Figure 5 displays boxplots of the SI for 
each experiment and center.  
In Experiment 1, higher average SIs were found for LPA (0.37±0.23), Lesion-TOADS 
(0.35±0.189) and kNN-TTP (0.44±0.14) than for Cascade (0.26±0.17) and LGA (0.31±0.23). The 
OER was relatively constant between the methods, whereas the DER showed more variation (see 
Table 5).  
Compared to Experiment 1, Experiment 2 did –on average– not reveal differences in spatial 
performance of any method. The small overall reduction in average spatial performance of Cascade, 
LGA, LPA and kNN-TTP in Experiment 2 does not imply that the performance always degrades 
when segmenting ‘unseen’ data. As can be seen from Figure 5, depending on the method, the 
performance on data from individual centers may actually also improve when using only data from 
other centers in the training set, see also Figure 4.  
 
3.3. Additional analyses 
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Table 6 displays the SI for each method for different ranges of the reference lesion volume. In 
general, independently of the method, an increase in average SI can be observed with increasing 
lesion volume.  
The spatial agreement for the different training set selection schemes is shown in Table 7. 
Independently of the training set selection scheme, all methods showed comparable performance. 
Table 8 presents the estimated sensitivity and specificity of the methods relative to the hidden 
truth computed by the STAPLE algorithm. On average, LPA, Lesion-TOADS and kNN-TTP showed 
higher estimated sensitivities and specificities than the two other methods.  
 
4. Discussion 
In this study we directly compared five research-domain automated WM lesion segmentation 
methods in a multi-center MS dataset, to obtain quantitative results on their volumetric and spatial 
performance in a multi-center dataset. Accurate and robust segmentation of WM lesions would be 
beneficial for clinical trials in which lesion volumes are used as a (secondary) study outcome and 
studies on accurately measuring the GM atrophy.23,24 Our results show performance differences 
between methods, with LPA, Lesion-TOADS and kNN-TTP overall exhibiting best performance, 
followed by Cascade and LGA. However, all methods were robust when applied to data of a new 
(‘unseen’) center, exhibiting very similar performance with and without inclusion of that center in the 
training and only using data of other centers. An interesting follow up study to improve the 
applications of the automated WM lesion segmentation methods in clinical setting, could be finding 
the optimal amount of centers or number of patients per center that should be used for the training.  
The systematic comparison in this study showed a good performance of LPA, Lesion-TOADS 
and kNN-TTP in terms of both volumetric and spatial performance. Cascade was comparable to these 
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for volumetric but not spatial agreement, while LGA showed lower volumetric and spatial agreement 
compared to LPA, Lesion-TOADS and kNN-TTP. Nevertheless, the spatial agreement of the 
methods with the manual reference segmentation in the current study (mean SI range [0.27-0.45]) 
was lower than commonly reported by earlier studies.15,25-27  To be able to compare the results of 
those study to the data of our study, we also report means and standard deviations. Because our data 
were mostly not normally distributed, the median, 1st and 3rd quartile are reported as Supplementary 
Table 10. As the boxplots do show that the performance of the methods stays comparable when 
reporting the median instead of the mean, we decided for better comparison of this study to other 
studies to report the mean. 
The lower spatial agreement found in the current work could result firstly reside from the fact 
that this study used a multi-center data set, which is by definition more heterogeneous than data from 
a single center and acquisition protocol. This is confirmed by another recent study on lesion 
segmentation in a multi-center data set, reporting similar (low) performances (range of SI=0.11-0.45) 
compared to the current study.28 The use of a multi-center data set is a strength of this study, 
providing a better approximation of the clinical setting, and moreover allowing us to show that the 
automated segmentation methods are robust to new data of an ‘unseen’ center. Summarizing, the four 
methods are robust, however, not accurate enough on spatial agreement. The relatively low spatial 
agreement may secondly be explained by the use of 2D FLAIR images instead of 3D FLAIR, 
because other studies that reported a higher SI used 3D FLAIR. 15,29 A higher SI with 3D FLAIR is 
probably due to the (normally) better resolution of the 3D images compared to 2D sequences, which 
results in more precise distinction of lesion boundaries and can also improve image co-registration. 
The use of 2D sequences may be considered a limitation of this study, because of the recent expert 
opinion guidelines and recommendation 30-32 and also because it is not possible to investigate cortical 
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lesions from this type of sequence. However, given our research question, aiming to accommodate 
the lack of multi-center validations of automated MS WM lesion segmentation techniques, this study 
was performed with data that is representative for the clinical practice. A follow up study could 
benefit from using data that is even more representative for the current clinical practice, so not only 
use 2D and 3D FLAIR images, 2 scanners and one field strength, but also include more different 
scanner or even scanners with both 1.5T and 3T field strengths.  
Another explanation for the relatively low spatial agreement in our study may be sought in the 
composition of the data set. The patients participating in the current study had on average a relatively 
low lesion burden (according to the manual rater: 4.85±7.29 mL), with even a few patients with 
extremely low burden. In two of those cases, none of the automated methods agreed with the manual 
reference on the location of the lesions, leading to zero overlap. Moreover, especially LGA produced 
more segmentations without agreement with the manual reference, resulting in a lower average SI 
and varying results for specific centers (i.e., center F).  
In addition, the training set selection scheme still can play a crucial role in the low spatial 
agreement. In this study we constructed the training set by selecting the subjects with the median, 
second lowest and second highest lesion loads for each center reasoning that these subjects properly 
reflect the data contributed by each center. This also ensured that each center was equally represented 
in the parameter tuning irrespective of the total number of subjects per center. However, this 
selection scheme may have had consequences for the final segmentation depending on the classifier 
within each method. To rule out that this had an effect we did an additional experiment using the 
patients with the three lowest and three highest lesion volumes for parameter tuning. This did not 
reveal large differences in performance for the methods evaluated in this study, but future studies 
should investigate the influence of training dataset composition more exhaustively. For example. 
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future studies could have a larger test set, because in our additional experiment the test set had only 
25 subjects. Such future work could also study optimum numbers and compositions for the training 
set, whether or not this should depend on the number of subjects for each center. Moreover, the 
lesion volumes could have more variation . 
The generally low spatial agreement was driven by both high DER and high OER, so both 
error in the detections of lesions as in outlining of the lesions, although the substantially lower 
performance of Cascade and LGA can be attributed in particular to a higher DER. Cascade and LGA 
had higher FP volumes than the other two methods. 
Concerning false negative voxels, all automated methods had around 2 mL average FN lesion 
volume. This may derive from the limitation that this study only used one single expert rater to 
construct the manual reference dataset, the rater possibly being too conservative in detecting and 
outlining the WM lesions. To address this issue, we took an alternative approach and compared the 
performance of the automated segmentations with the data-driven STAPLE algorithm. This 
algorithm does not require manual data, but estimates the sensitivity and specificity of the different 
methods by comparing to the ‘hidden true segmentation’ that is constructed by the STAPLE 
algorithm using the four automated segmentations. This analysis showed similar results as when 
comparing to the manual reference, with LPA, Lesion-TOADS and kNN-TTP showing better 
performance than Cascade and LGA. This confirms the observation from the manual reference 
comparison that Lesion-TOADS and kNN-TTP had best performance in terms of spatial agreement. 
Future studies should try to improve construction of the manual segmentations, possibly by using 
intelligent data-driven approaches or a larger number of manual raters, of which the agreement in 
terms of lesion detection and outline error can be quantified. 
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The results of this study also shows that improvements in terms of volumetric agreement are 
necessary, as the average volumetric difference between the manual reference and automated 
methods ranged from 0.44±4.68 (kNN-TTP) to 2.31±7.66 mL (LGA). When visualily inspecting the 
outlines and MR images of these outliers we concluded that this was mainly due to GM atrophy in 
these subjects. By comparison, the average lesion load changes occurring in MS patients over a 1-
year period in clinical studies are in ranges of 0.38±1.81,3 0.11±2.55,5 and 0.08±0.97 mL.6 The large 
inter-subject variability of the volumetric differences within each method indirectly suggests that the 
errors are not entirely systematic, and therefore these errors are a concern for detecting the lesion 
volume changes over time. Future studies should investigate performance at quantifying lesion 
volume change over time using suitable datasets and with high-quality reference measurements. 
Further studies could help optimize performance by investigating the dependence of performance on 
lesion location and on total lesion load. Moreover, a follow up study could look with more detail to 
different lesions types and locations. 
In conclusion, the five research-domain automated WM lesion segmentation methods 
exhibited moderate accuracy in this multi-center dataset consisting of MS patients with moderate 
lesion burden. All methods exhibited relatively low performance compared to other studies. LPA, 
Lesion-TOADS and kNN-TTP outperformed Cascade and LGA in terms of both volumetric and 
spatial agreement. The performance of the method was not affected by using ‘unseen’ data for 
training, which is important for the acceptance of automated methods in a clinical setting. However, 
the methods should perform better before their use in a clinical setting can be realistically considered. 
Furthermore, better understanding of which parameters influence the performance of the 
segmentation methods is required for better interpreting their performance. 
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Tables 
 
Table 1 Demographics of MS patientsa 
Center 
 
Nb 
 
Age 
years 
Disease types 
 
DD 
years 
EDSSc 
 
A 14 [86%] 37.6±7.2 1 CIS, 13 RR 11.5±8.6 2.5 (0.0-6.5) 
B 11 [73%] 28.1±8.6 11 RR 7.6±4.8 2.5 (1.0-4.0) 
C 10 [80%] 35.2±10.5 10 RR 3.6±1.3 2.0 (0.0-6.5) 
D 14 [64%] 35.6±10.0 14 RR 5.3±3.3 1.5 (0.0-3.0) 
E 11 [80%] 34.2±3.6 11 RR 7.5±4.4 2.5 (1.0-3.5) 
F 10 [10%] 38.4±9.4 6 RR, 4 SP 9.2±7.2 4.0 (1.5-6.5) 
Total 70 [67%] 34.9±8.5 1 CIS, 65 RR, 4 SP 7.6±6.0 2.0 (0.0-6.5) 
aMean±standard deviation 
bNumber of subjects [%female] 
cMedian (range)  
Abbreviations: DD=disease duration, EDSS=expanded disability status scale, CIS = clinically 
isolated syndrome RR=relapsing-remitting, SP=secondary-progressive 
 
Table 2 An overview of the acquisition parameters for each center 
  
 Sequence parameters 2D 
FLAIR/3DT1 
 
Center 
 
Scanner brand,  
scanner type 
 TR  
(ms) 
TE  
(ms) 
TI 
(ms) 
FA  
(⁰) 
Voxel size (mm3) 
A Siemens, Trio 
2D FLAIR 
3DT1 
9000 
2300 
93 
2.98 
2500 
900 
- 
9 
256x256 (0.94x0.94x3) 
182x240 (1x1x1) 
B Siemens, Trio 
2D FLAIR 
3DT1 
9000 
1570 
136 
2.76 
2500 
900 
- 
9 
320x320 (0.75x0.75x3) 
160x256 (1x1x1) 
C Philips, Achieva 
2D FLAIR 
3DT1 
11000 
6.9 
125 
2.78. 
2600 
831 
- 
9 
256x256(0.94x0.94x3) 
160x240(1x1x1) 
D Siemens, Trio 
2D FLAIR 
3DT1 
10000 
1900 
69 
2.19 
2500 
900 
- 
9 
256x256 (0.94x0.94x3) 
176x448 (1x1x1) 
E Philips, Achieva 
2D FLAIR 
3DT1 
8000 
6.9 
125 
3.1 
2400 
831 
- 
8 
240x180 (1x1x3) 
256x256 (1x1x1) 
F Philips, Achieva 
2D FLAIR 
3DT1 
11000 
8.3 
120 
3.7 
2800 
815 
- 
8 
256x256 (0.94x0.94x3) 
182x240 (1x1x1) 
Abbreviations: FLAIR=fluid-attenuated inversion recovery, TR=repetition time, TE=echo time, 
TI=inversion time, FA=flip angle;  
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Table 3 Description of the methods, parameter tuning and pre- and post-processing steps of automated segmentation methods 
Method Reference Underlying method Parameter tuning Pre-processing Post-processing 
Cascade Damangir, 2012 SVM;  
Statistical definition 
of WML 
Yes; α and  
LPV threshold 
Brain extraction on 3DT1 
3DT1 to FLAIR registration 
Brain mask applied on FLAIR  
Not needed 
LGA Schmidt, 2012 Algorithm based  Yes; κ and LPT Generate PVE label image 
coregistration FLAIR to 3DT1 
registration TPMWM to 3DT1 
Needed; 
LP maps to FLAIR 
registration 
LPA Schmidt; 2017 Algorithm based  Yes; LPT Generate PVE label image 
coregistration FLAIR to 3DT1 
registration TPMWM to 3DT1 
Needed; see LGA 
Lesion-
TOADS 
Shiee, 2010 Topological and 
Statistical atlas based 
None Brain extraction on 3DT1 
3DT1 to FLAIR registration 
Brain mask applied on FLAIR  
Not needed 
kNN-TTP Steenwijk, 2013 kNN classification Yes; LPT Brain extraction on 3DT1 
3DT1 to FLAIR registration 
Brain mask applied on FLAIR  
Not needed 
Abbreviations: SVM=support vector machine, PVE=partial volume estimate, TPMWM=white matter tissue probability map, 
FLAIR=fluid-attenuated inversions recovery, LPV=lesion pvalue, LPT=lesion probability threshold, LP=lesion probability  
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Table 4 Optimal setting for threshold  
 
    Training on  Center excluded from training 
Method Parameter all centers A B C D E F 
Cascade α 0.10 0.10 0.10 0.10 0.10 0.10 0.10 
 Lesion-pvalue 0.05 0.05 0.05 0.05 0.05 0.15 0.05 
LGA  κ 0.15 0.20 0.20 0.15 0.15 0.20 0.20 
 
Lesion-
probability 
0.85 0.75 0.65 0.85 0.75 0.75 0.75 
LPA 
Lesion-
probability 
0.55 0.55 0.55 0.60 0.55 0.55 0.55 
Lesion-TOADS None        
kNN-TTP 
 
Lesion-
probability 
0.55 0.55 0.50 0.55 0.65 0.55 0.55 
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Table 5 Volumetric and Spatial agreement of the automated methods with the manual referencea 
  
Test 
set  
Method 
 
Volumeb 
 
Volume 
differenceb 
ICC 
 
SI 
 
DER 
 
OER 
 
FN 
Volumeb 
FP 
Volumeb 
  
Manual 
reference 
4.85±7.29 
 
       
Experiment 1c N=52 Cascade 5.45±6.47 0.60±4.83 0.755 0.26±0.17 0.98±0.55 0.50±0.35 2.28±3.04 3.64±3.44 
   LGA 7.16±12.70 2.31±7.66 0.713 0.31±0.23 0.83±0.70 0.56±0.34 2.70±4.73 2.93±10.03 
  LPA 5.30±9.63 0.44±4.68 0.851 0.37±0.23 0.59±0.45 0.68±0.27 1.71±2.44 2.92±1.82 
   
Lesion-
TOADS  
7.45±7.97 
 
1.76±4.17 
 
0.806 
 
0.35±0.18 
 
0.65±0.50 
 
0.64±0.34 
 
1.36±1.75 
 
4.73±4.11 
 
    
kNN-
TTP 
5.92 ±6.42 
 
-1.39±4.10 
 
0.723 
 
0.44±0.14 
 
0.49±0.38 
 
0.62±0.24 
 
2.30±4.01 
 
1.51±1.79 
 
Experiment 2c N=52 Cascade 5.44±6.48 0.75±4.56 0.774 0.23±0.18 0.96±0.57 0.58±0.47 2.26±3.05 4.11±8.32 
  LGA 8.15±17.06 3.45±12.12 0.550 0.32±0.23 0.82±0.70 0.55±0.33 2.41±3.56 5.67±14.21 
  LPA 5.16±9.65 0.46±5.25 0.809 0.36±0.17 0.59±0.45 0.68±0.32 1.72±2.51 2.89±4.83 
  
Lesion-
TOADS 
7.45±7.97 
 
2.60±4.18 
 
0.806 
 
0.35±0.18 
 
0.66±0.50 
 
0.64±0.34 
 
1.36±1.75 
 
4.73±4.11 
 
  
kNN-
TTP 
3.32±4.17 
 
-1.53±4.26 
 
0.738 
 
0.43±0.14 
 
0.49±0.38 
 
0.62±0.24 
 
2.28±4.00 
 
1.15±1.68 
 
aMean±standard deviation 
bVolume in mL 
cCenters were combined in experiment 2 
Abbreviations: N=number of subjects, ICC=intra-class correlation coefficient, SI=similarity index, DER=detection error rate, 
OER=outline error rate, FN =false negative, FP=false positive 
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Table 6: SI for different lesion volumesa 
Volume Test set  Method  SI 
<5mL  N=34 Cascade 0.21±0.14 
  LGA 0.28±0.22 
  LPA 0.32±0.16 
  
Lesion-
TOADS 
0.29±0.15 
 
  kNN-TTP 0.42±0.14 
5-15mL N=12 Cascade 0.36±0.17 
  LGA 0.33±0.27 
  LPA 0.49±0.07 
  
Lesion-
TOADS 
0.48±0.13 
 
  kNN-TTP 0.49±0.11 
>15mL N=6 Cascade 0.50±0.14 
  LGA 0.45±0.23 
  LPA 0.46±0.19 
  
Lesion-
TOADS 
0.63±0.08 
 
  kNN-TTP 0.50±0.18 
aMean±standard deviation 
Abbreviations: N=number of subjects, 
SI=similarity index. 
 
Table 7: SI of the original test set and obtained in only the patients present in the test sets for 
different used training setsa 
Training 
set  
Original 
(N=52) 
A 
(N=28) 
B 
(N=28) 
C 
(N=28) 
Method     
Cascade 0.26±0.17 0.33±0.12 0.32±0.15 0.31±0.16 
LGA 0.31±0.23 0.36±0.22 0.35±0.22 0.35±0.22 
LPA 0.37±0.17 0.44±0.13 0.44±0.14 0.43±0.13 
Lesion-
TOADS 
0.35±0.18 0.44±0.16 
 
0.44±0.16 
 
0.44±0.16 
 
kNN-TTP 0.42±0.17 0.50±0.11 0.51±0.11 0.49±0.13 
aMean±standard deviation 
Abbreviations: N=number of subjects, SI=similarity 
index. 
Training sets: for each center for original and A the 
patients with the median, second minimum and second 
maximum lesion volumes, for B the three patients with 
lowest lesion volume and for C the three patients with 
highest lesion leas. 
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Table 8: Estimated sensitivity and specificity compared to data-driven reference 
Method 
 
Test set  
(N=52) 
Estimated  
sensitivity 
Estimated 
specificity  
Cascade  0.55±0.27 0.38±0.31 
LGA   0.69±0.22 0.56±0.37 
LPA  0.81±0.13 0.78±0.23 
Lesion-
TOADS  
  
0.81±0.24 
 
0.61±0.25 
 
KNN-TTP   0.75±0.13 0.72±0.24 
aMean±standard deviation 
Abbreviations: N=number of subjects 
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Figures 
 
 
Figure 1: Flowchart of selection method for training and test set. The number of patients in test 
set when select center Xi, depends on the selected centers. Abbreviations: N=number of 
subjects.  
 
 
Figure 2: A FLAIR images is shown (first from left) with the lesion masks of the manual 
reference (second from left) and the 4 segmentation methods (images 3 to 6 from left). 
Abbreviations: FLAIR=FLuid-Attenuated Inversion Recovery 
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Figure 3: Lesion volume between automated segmentations (left to right, up to down; Cascade, LGA, LPA, Lesion-TOADS and kNN-
TTP) against the lesion volume of the manual reference. 
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Figure 4: Boxplot of difference in lesion volume between automated segmentations (left to right; Cascade trained on all centers and 
Cascade trained on other centers, LGA trained on all centers and LGA trained on other centers, LPA trained on all centers and LPA 
trained on other centers, Lesion-TOADS trained on all centers and Lesion-TOADS trained on other centers and kNN-TTP trained on 
all centers and kNN-TTP trained on other centers) and the manual reference for the total group and separate centers (left to right: 
all, center A, B .. F), with star = outliner, diamond = mean of difference, green line is zero. 
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Figure 5: Boxplot of the Similarity Index (left to right; Cascade trained on all centers and Cascade trained on other centers, LGA 
trained on all centers and LGA trained on other centers, LPA trained on all centers and LPA trained on other centers, Lesion-
TOADS trained on all centers and Lesion-TOADS trained on other centers and kNN-TTP trained on all centers and kNN-TTP 
trained on other centers) and the manual reference for the total group and separate centers (left to right: all, center A, B .. F), with 
star=outliner, diamond=mean. 
 
 
